US 8669249
Poly (ADP-ribose) polymerase (PARP) inhibitors
granted A61PA61P1/02A61P1/04
Quick answer
US patent 8669249 (Poly (ADP-ribose) polymerase (PARP) inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P1/02, A61P1/04, A61P11/00, A61P11/06